Christos Ierna is an associate in the Paris office of Latham & Watkins. He primarily advises clients on corporate law, mergers and acquisitions, and private equity.
Christos Ierna
Associate
Profile
Experience
Mr. Ierna's experience includes advising:
- General Catalyst on the €385 million Series A financing round of Mistral AI, a French start-up specializing in generative artificial intelligence
- Inari Medical in its acquisition of LimFlow
- ArchiMed Portfolio Company, Natus Medical Incorporated, in its acquisition of Micromed, a global provider of neurophysiology solutions
- Astorg Partners in its the binding agreement to acquisition ofre CordenPharma, a leading pharmaceutical contract development and manufacturing organization, from International Chemical Investors Group (ICIG)
- TA Associates in its acquisition of a majority growth investment in DL Software
- Ardian in:
- its acquisition of a majority stake in Inula Group, a France-based company that the develops, produces, and distributes phytotherapeutic remedies
- the sale of the Kersia group (global leader in biosecurity and food safety), other co-investors, and managers to IK Investment Partners
- Atomico in its investment in Sorare’s Series B raise, the largest ever in the non-fungible token (NFT) space
- Körber, an international technology company, in the sale of a minority stake in its supply chain software business to KKR
- SHD in the acquisition of a majority stake in Pragma Informatique
Qualifications
Bar Qualification
- Avocat (Paris)
- New York
Education
- Master of Laws (LL.M.), University of Pennsylvania Law School, 2017
- Postgraduate Degree Finance, Sciences Po Paris, 2017
- Business and Law Certificate, Wharton School, University of Pennsylvania, 2017
- Diploma in Law, University of Oxford, 2014
- Master of Law, Université Paris II, Panthéon-Assas, 2014
Languages Spoken
- English
- French
- Greek
- Italian
Practices
News & Insights
December 11, 2023
Our Work
Paris team represents investor on fundraising of leading French generative AI company.
November 10, 2023
Our Work
Latham & Watkins Advises Inari Medical in Acquisition of LimFlow
Cross-border team advises the medical device company in expansion of its patient-focused mission.
January 27, 2023
Our Work
May 4, 2022
Our Work
December 14, 2021
Our Work